These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21401567)

  • 1. Testing for interaction in two-way random and mixed effects models: the fully nonparametric approach.
    Gaugler T; Akritas MG
    Biometrics; 2011 Dec; 67(4):1314-20. PubMed ID: 21401567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues in use of SAS PROC.MIXED to test the significance of treatment effects in controlled clinical trials.
    Ahn C; Tonidandel S; Overall JE
    J Biopharm Stat; 2000 May; 10(2):265-86. PubMed ID: 10803729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratified tests, stratified slopes, and random effects models for clinical trials with missing data.
    Dawson JD; Han SH
    J Biopharm Stat; 2000 Nov; 10(4):447-55. PubMed ID: 11104386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
    Siddiqui O; Hung HM; O'Neill R
    J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonparametric procedure for the two-factor mixed model with missing data.
    Gao X
    Biom J; 2007 Aug; 49(5):774-88. PubMed ID: 17634980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined linkage and association mapping of quantitative trait Loci with missing completely at random genotype data.
    Fan R; Liu L; Jung J; Zhong M
    Behav Genet; 2008 May; 38(3):316-36. PubMed ID: 18306033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of missing data on type 1 error rates in non-inferiority trials.
    Yoo B
    Pharm Stat; 2010; 9(2):87-99. PubMed ID: 19408241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics.
    Brannath W; Bretz F; Maurer W; Sarkar S
    Biom J; 2009 Dec; 51(6):885-98. PubMed ID: 20014203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust alternatives to the F-Test in mixed linear models based on MM-estimates.
    Copt S; Heritier S
    Biometrics; 2007 Dec; 63(4):1045-52. PubMed ID: 17484776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I and Type II error under random-effects misspecification in generalized linear mixed models.
    Litière S; Alonso A; Molenberghs G
    Biometrics; 2007 Dec; 63(4):1038-44. PubMed ID: 17425642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Likelihood ratio testing of variance components in the linear mixed-effects model using restricted maximum likelihood.
    Morrell CH
    Biometrics; 1998 Dec; 54(4):1560-8. PubMed ID: 9883552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the adequacy of variance function in heteroscedastic regression models.
    Wang L; Zhou XH
    Biometrics; 2007 Dec; 63(4):1218-25. PubMed ID: 17484775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data.
    Stijnen T; Hamza TH; Ozdemir P
    Stat Med; 2010 Dec; 29(29):3046-67. PubMed ID: 20827667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problematic formulations of SAS PROC.MIXED models for repeated measurements.
    Overall JE; Ahn C; Shivakumar C; Kalburgi Y
    J Biopharm Stat; 1999 Mar; 9(1):189-216. PubMed ID: 10091918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of non-normality on test statistics for one-way independent groups designs.
    Cribbie RA; Fiksenbaum L; Keselman HJ; Wilcox RR
    Br J Math Stat Psychol; 2012 Feb; 65(1):56-73. PubMed ID: 21426313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A note on permutation tests for variance components in multilevel generalized linear mixed models.
    Fitzmaurice GM; Lipsitz SR; Ibrahim JG
    Biometrics; 2007 Sep; 63(3):942-6. PubMed ID: 17403100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The two-way mixed model: a long and winding controversy.
    Ato García M; Vallejo Seco G; Palmer Pol A
    Psicothema; 2013 Feb; 25(1):130-6. PubMed ID: 23336555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical Bayes screening of many p-values with applications to microarray studies.
    Datta S; Datta S
    Bioinformatics; 2005 May; 21(9):1987-94. PubMed ID: 15691856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.